SCHEMBL5745878

SCHEMBL5745878

CNc1nc(-c2ccc(F)c3ccccc23)cc(C(C)C)n1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1B P28222 1/20 0.67
HTR2B P41595 1/20 0.67
GPR65 Q8IYL9 1/20 0.67
TDP1 Q9NUW8 1/20 0.40
CRHBP P24387 2/20 0.36
CRHR2 Q13324 2/20 0.36
FEN1 P39748 2/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
TSHR P16473 1/20 0.36
CYP2C19 P33261 1/20 0.36
ADORA1 P30542 4/20 0.34
ADORA2A P29274 2/20 0.34
KDM4E B2RXH2 5/20 0.34
NPSR1 Q6W5P4 2/20 0.33
ADORA2B P29275 2/20 0.33
ADORA3 P0DMS8 1/20 0.33
RECQL P46063 1/20 0.33
NUDT1 P36639 1/20 0.33
GPR39 O43194 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL5750394 0.87 HTR1B (0.68) HTR1BHTR2BGPR65CRHBPCRHR2
Hydrochloric Acid SCHEMBL5776576 0.86 HTR1B (0.60) HTR1BHTR2BGPR65CRHBPCRHR2
SCHEMBL5750582 0.86 HTR1B (0.63) HTR1BHTR2BGPR65CRHBPCRHR2
SCHEMBL5750023 0.86 HTR1B (0.63) HTR1BHTR2BGPR65TSHR
SCHEMBL5748124 0.85 HTR1B (0.62) HTR1BHTR2BGPR65CRHBPCRHR2
Hydrochloric Acid SCHEMBL7132300 0.84 HTR1B (0.58) HTR1BHTR2BGPR65CRHBPCRHR2
SCHEMBL5749566 0.84 HTR1B (0.60) HTR1BHTR2BGPR65CRHBPCRHR2
SCHEMBL5746388 0.84 HTR1B (0.64) HTR1BHTR2BGPR65FEN1ADORA1
SCHEMBL5750661 0.84 HTR1B (0.60) HTR1BHTR2BGPR65CRHBPCRHR2
SCHEMBL8386261 0.84 HTR1B (0.64) HTR1BHTR2BGPR65CRHBPCRHR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0901474-B1 ARYL PYRIMIDINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2006-04-19 EP claimed
CN-1109675-C Aryl pyrimidine derivatives HOFFMANN LA ROCHE (CH) 2003-05-28 CN claimed
US-5952331-A SELECTIVE 5HT2B ANTAGONISTS; SEROTONIN RECEPTOR ANTAGONIST; TREATING DISORDERS OF THE GASTROINTESTINAL TRACK, RESTENOSIS, ASTHMA AND OBSTRUCTIVE AIRWAY DISEASE, PROSTATIC HYPERPLASIA, GENERALIZED ANXIETY, PANIC DISORDER SYNTEX (USA) INC. (US) 1999-09-14 US claimed
CN-1223641-A Aryl pyrimidine derivatives HOFFMANN LA ROCHE (CH) 1999-07-21 CN claimed
EP-0901474-A1 ARYL PYRIMIDINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 1999-03-17 EP claimed
US-5863924-A Aryl pyrimidine derivatives SYNTEX (U.S.A.) INC. (US) 1999-01-26 US claimed
WO-1997044326-A1 ARYL PYRIMIDINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 1997-11-27 WO claimed
EP-0901474-B1 ARYL PYRIMIDINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2006-04-19 EP disclosed
EP-1321169-A1 Combination of a serotonin receptor antagonist with a histidine decarboxylase inhibitor as a medicament Biofrontera Pharmaceuticals AG (DE) 2003-06-25 EP disclosed
CN-1109675-C Aryl pyrimidine derivatives HOFFMANN LA ROCHE (CH) 2003-05-28 CN disclosed
US-5958934-A 5-HT 2B ANTAGONIST SYNTEX (U.S.A.) INC. (US) 1999-09-28 US disclosed
US-5952331-A SELECTIVE 5HT2B ANTAGONISTS; SEROTONIN RECEPTOR ANTAGONIST; TREATING DISORDERS OF THE GASTROINTESTINAL TRACK, RESTENOSIS, ASTHMA AND OBSTRUCTIVE AIRWAY DISEASE, PROSTATIC HYPERPLASIA, GENERALIZED ANXIETY, PANIC DISORDER SYNTEX (USA) INC. (US) 1999-09-14 US disclosed
CN-1223641-A Aryl pyrimidine derivatives HOFFMANN LA ROCHE (CH) 1999-07-21 CN disclosed
EP-0901474-A1 ARYL PYRIMIDINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 1999-03-17 EP disclosed
US-5863924-A Aryl pyrimidine derivatives SYNTEX (U.S.A.) INC. (US) 1999-01-26 US disclosed
WO-1997044326-A1 ARYL PYRIMIDINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 1997-11-27 WO disclosed